HEALTH

Allergan appoints Dawn Hudson to board

BY Michael Johnsen

IRVINE, Calif. Allergan on Friday named Dawn Hudson to the company’s board, effective Jan. 28. Hudson is the former president and chief executive officer of Pepsi-Cola North America. In addition, Hudson served as chief executive officer of the PepsiCo foodservice division, which integrated the relevant units of PCNA and Frito-Lay North America with the Quaker, Tropicana and Gatorade brands.

“Hudson’s expertise and insights as a pioneer in brand development and consumer behavior will further strengthen Allergan’s leadership skills in consumer marketing,” stated David Pyott, Allergan’s chairman and chief executive officer. “Building on Allergan’s success record in developing and expanding markets, I am confident Ms. Hudson will add significant value in evaluating innovative practices and channels to help drive greater consumer awareness and appeal for Allergan’s core products.”

Hudson will initially serve as a member of the audit and finance committee and the organization and compensation committee.

Previously, Hudson served as vice chair of the American Beverage Association. She currently sits on the board of Lowe’s home improvement stores and is chairman of the Ladies Professional Golf Association.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

FDA approves Confidant mobile phone system for OTC sales

BY Drew Buono

RESEARCH TRIANGLE PARK, N.C. The Food and Drug Administration has given Confidant market clearance for the over-the-counter sale of its chronic disease management product. Confidant is a manufacturer of mobile communication solutions for chronic disease management.

In May 2005, Confidant became the first company to receive clearance from the FDA for a mobile phone-based system to communicate with multiple home medical devices. This was followed by the October 2006 clearance, which included significant user interface improvements and the ability to work with a broader group of home medical devices.

Initially, the focus was on home diabetes management, with the system being capable of collecting data from a range of glucose meters, weight scales and blood pressure devices. With the OTC product, users can collect data from the same full range of off-the-shelf devices supported by the company’s prescription product. Objective and motivational feedback is returned directly to the user’s cell phone within seconds and automatic reminders help the user keep on track with routine monitoring.

Patient data can be accessed directly through the Confidant portal or by accessing Personal Health Record or Electronic Medical Record systems that are populated from the Confidant system.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Gerolymatos announces Breathe Again is top seller in U.S.

BY Michael Johnsen

NEW YORK Earlier this year, Gerolymatos introduced its European nasal saline spray, Breathe Again with Sinomarin, to the United States, where it has become a top seller, the company announced in a press release Monday. According to Information Resources data as provided by Gerolymatos, Breathe Again was the leading saline nasal spray in the drug stores for the month of October.

Breathe Again with SinoMarin nasal spray is harvested from pure tidal seawater off France’s Atlantic coast, and then filtered and mixed with purified water in a ratio that closely mirrors the body’s interstitial fluid. It is an all natural hypertonic saline solution that helps to clean, clear and moisturize nasal passages.

Breathe Again is now available at Wal-Mart, Walgreens, Rite Aid and other major drug and supermarket retailers in both adult and pediatric formulas. The suggested retail price is $9.99.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?